iData Research Logo

A Trusted Source of Intelligent Data

  • Solutions
    • Subscription Model *NEW*
    • Healthcare Market Reports
    • MedSKU Brand Analysis
    • Procedure Tracker
    • Medical Market Surveys
    • Total Sales Solution
    • Custom Consulting
    • iData Pharma
    • iData Online
  • Reports
  • Platforms
  • News
    • MedTech Future
    • CardioFuture
    • DentalFuture
    • OrthoFuture
    • COVID-19
    • Press Releases
  • About Us
    • About Us
    • Do it Right
    • Research Methodology
    • Careers
    • Testimonials
    • FAQs
  • Contact Us
  • Serach
  • Login
Sign In
Home Dialysis Arteriovenous Access
Research Categories
  • Anesthesia
  • Arthroscopy
  • Biologics/Biomaterials
  • Cancer Devices
  • Cardiovascular
  • Cosmetic Devices
  • Dental
  • Diabetes
  • Diagnostics
  • Dialysis
  • Drug Delivery
  • Ear, Nose, Throat
  • Endoscopy
  • Gastrointestinal (GI)
  • General Surgery
  • Gynecology Devices
  • Healthcare IT
  • Hearing Devices
  • Imaging
  • Immunology
  • In-Vitro Diagnostics
  • Infusion Therapy
  • Laparoscopy
  • Minimally Invasive Surgery
  • Neurology Devices
  • Oncology
  • Operating Room Equipment
  • Ophthalmics Devices
  • Orthopedics
  • Patient Monitoring
  • Peripheral Vascular
  • Respiratory Devices
  • Robotics & Navigation
  • Sleep Apnea & Diagnostics
  • Spine
  • Stents
  • Telehealth & Telemedicine
  • Tissue Repair
  • Urology
  • Vascular Access
  • Video Hi-Tech
  • Women's Health
  • Wound Care

Arteriovenous Access

Showing all 2 resultsSorted by latest

  • AV Grafts Market Analysis | United States | 2017-2023 | MedCore

    Infusion Pump Global MedCore

    Arteriovenous (AV) is the most common method of access for hemodialysis treatment in patients that are suffering from end-stage renal disease (ESRD). AV access can be achieved via either AV fistula or AV graft. The fistula can be made in an extremity, typically in the forearm, where an artery and vein are surgically connected. This connection matures and strengthens over a period of four to six weeks. Native fistulae offer the best patency and durability, in addition to limiting complications such as post-dialysis bleeding and infection. A native fistula is the preferred access technique.

    more...
  • AV Fistula Needles Market Analysis | United States | 2017-2023 | MedCore

    Infusion Pump Global MedCore

    An AV fistula needle enables access to the patient’s circulatory system and permits the flow of blood from the patient, to the dialyzer’s blood compartment and then back into the patient’s bloodstream. An AV fistula needle is used for patients with either an AV fistula or an AV graft; however, they are not required for patients implanted with a dialysis catheter.

    more...
  • Not finding what you’re looking for? Please call us at +1 604 266 6933 or

    Contact Us

    Subscribe to our Newsletter
    Subscribe

    OUR ADDRESS

    • 602-7300 Edmonds St, Kings Crossing, Burnaby, BC V3N 0G8, Canada
    • 8 The Green #21910, Dover, DE, 19901, United States
    • +1 (604) 266-6933
    • info@idataresearch.net

    SOLUTIONS

    • Report
    • Custom Consulting
    • MedSKU Brand Analysis
    • Procedure Tracker
    • Surveys
    • Total Sales Solution
    • Pharmaceuticals
    • iDataOnline

    NEWS

    • Blog
    • MedTech Future
    • Cardio Future
    • Dental Future
    • Ortho Future
    • Subscribe

    ABOUT US

    • About iData
    • Our Methodology
    • Testimonials
    • FAQ
    • Careers

    OTHER

    • Terms of Use
    • Privacy Policy
    • Sitemap

    Copyright © 2005 - 2026 iData Research. All Rights Reserved